The Company is continuing to work diligently to finalize and file the Form 20-F as soon as possible within the timeline prescribed by Nasdaq. However, there can be no assurance that the Company will ...

On April 24, the Federal Reserve withdrew its prior guidance for banks related to their crypto-asset and dollar token activities and also ...

Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula, targeting the SARS-CoV-2 ...

Of the proceeds received from the consummation of the initial public offering (including the full exercise of the over-allotment option by the underwriters) and a simultaneous private placement of ...

The Staff’s most recent actions continue to set the stage for notice-and-comment rulemaking long-awaited by the digital asset industry.

Caris Life Sciences filed for an initial public offering with the Securities and Exchange Commission. It plans to list on the Nasdaq under the ticker symbol CAI. The company didn't list an expected ...